SCHEMBL4091973

SCHEMBL4091973

COc1ccc2c(C3CC(O)c4ccccc43)c[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.46
HTR2A P28223 2/20 0.46
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
IDO1 P14902 1/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
TUBB1 Q9H4B7 1/20 0.42
PDE4D Q08499 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
HTR6 P50406 1/20 0.40
RECQL P46063 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSD11B1 P28845 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4091963 1.00 MAPT (0.46) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4091967 1.00 MAPT (0.46) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL14263100 0.84 HTR2A (0.43) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4088917 0.84 HTR2A (0.43) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4097291 0.84 HTR2A (0.43) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4106434 0.83 HTR2A (0.47) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4088908 0.83 HTR2A (0.47) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4097287 0.83 HTR2A (0.47) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4088913 0.83 HTR2A (0.47) MAPTHTR2AHTR2CHTR2BIDO1
SCHEMBL4103323 0.80 IDO1 (0.53) HTR2AHTR2CHTR2BIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618967-B2 Indane compounds H. LUNDBECK A/S (DK) 2009-11-17 US disclosed
US-20090215774-A1 USES OF INDANE COMPOUNDS H. LUNDBECK A/S (DK) 2009-08-27 US disclosed
US-20080058329-A1 NOVEL INDANE COMPOUNDS H. LUNDBECK A/S (DK) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058329-A1 NOVEL INDANE COMPOUNDS OPRL1, HTR2C, SLC6A3 MAPT 33/4885HTR2A 15/4885HTR2C 2/4885
US-20090215774-A1 USES OF INDANE COMPOUNDS GPR119, INSR, IRS1 MAPT 1869/4885HTR2A 103/4885HTR2C 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.